BioSpace News Archive

FDA

OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test

OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test.

December 8, 2021
·
4 min read
Drug Development

Tranquis Therapeutics Announces Initiation of Phase 1 Study of TQS-168

Tranquis Therapeutics today announced the initiation of dosing in a Phase 1 clinical study of TQS-168 in healthy volunteers.

December 8, 2021
·
3 min read
Genetown

H3 Biomedicine Presents Investigational Data Update on H3B-6545 for Treatment of Locally Advanced or Metastatic Estrogen Receptor- positive, HER2-negative Breast Cancer at San Antonio Breast Cancer Symposium

H3 Biomedicine Inc. today announced the presentation of two posters at the 2021 San Antonio Breast Cancer Symposium (SABCS) being held in a hybrid format on December 7- 10, 2021.

December 8, 2021
·
3 min read
Lone Star Bio

Nanoscope Therapeutics’ Optogenetic Gene Therapy to be Featured in Presentation at Stanford University’s Innovate Retina Summit Dec. 11, 2021

Nanoscope Therapeutics Inc announced today the company’s Multi-Characteristic Opsin (MCO) gene therapy platform will be featured in a presentation by Michael Singer, M.D., a member of Nanoscope’s Clinical Advisory Board, at Stanford University’s Innovate Retina summit on December 11, 2021.

December 8, 2021
·
2 min read
Devonian Health Group Announces Publication of Article on Potential Use of Thykamine™ in the Treatment of Covid-19 in the International Journal of Noncommunicable Diseases

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), announced today the publication of an article in the peer-reviewed International Journal of Noncommunicable Diseases describing the potential use of Thykamine™ as a therapeutic agent for Covid-19.

December 8, 2021
·
5 min read
Biotech Beach

EPIC sciences platform Demonstrates compelling Value of Cell Analysis in data Presented AT San Antonio Breast Cancer Symposium 2021

Epic Sciences, Inc. (Epic)'s comprehensive liquid-biopsy platform continues to deliver compelling cancer profiling information as data presented during the San Antonio Breast Cancer Symposium 2021 demonstrate.

December 8, 2021
·
2 min read
Pharm Country

Emendo Biotherapeutics to Present New Data at 63rd ASH Annual Meeting & Exhibition

Emendo Biotherapeutics, a next-generation CRISPR company expanding the reach of gene editing therapeutics, will be presenting a poster at the annual American Society of Hematology conference in Atlanta, taking place December 11-14, 2021.

December 8, 2021
·
1 min read
Heparin Market Revenue Growth Driven by Growing Prevalence of Chronic and Acute Diseases Worldwide: Reports and Data

Growing prevalence of chronic and acute diseases across the globe, increasing volumes of surgical procedures, and increasing use of anticoagulating agents are among the key factors expected to drive market revenue growth over the next few years.

December 8, 2021
·
9 min read
Biotech Bay

CooperCompanies Declares Cash Dividend - Dec 08, 2021

CooperCompanies announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2022, to stockholders of record on January 21, 2022.

December 8, 2021
·
1 min read
Sports Medicine Market Revenue Driven by Increasing Incidence of Sports & Exercise-Related Injuries Worldwide: Reports and Data

Technological advancements in healthcare infrastructure, increasing R&D investments, and rising public awareness of diabetes about sports medicines are some key factors expected to drive market growth.

December 8, 2021
·
7 min read